Activation of Gq-type G protein-coupled receptors (GPCRs) gives rise to large cytosolic Ca2+ elevations in astrocytes. Previous in vitro and in vivo studies have indicated that astrocytic Ca2+ elevations are closely associated with diameter changes in the nearby blood vessels, which astrocytes enwrap with their endfeet. However, the causal relationship between astrocytic Ca2+ elevations and blood vessel diameter changes has been questioned, as mice with diminished astrocytic Ca2+ signaling show normal sensory hyperemia. We addressed this controversy by imaging cortical vasculature while optogenetically elevating astrocyte Ca2+ in a novel transgenic mouse line, expressing Opto-Gq-type GPCR Optoα1AR (Astro-Optoα1AR) in astrocytes. Blue light illumination on the surface of the somatosensory cortex induced Ca2+ elevations in cortical astrocytes and their endfeet in mice under anesthesia. Blood vessel diameter did not change significantly with Optoα1AR-induced Ca2+ elevations in astrocytes, while it was increased by forelimb stimulation. Next, we labeled blood plasma with red fluorescence using AAV8-P3-Alb-mScarlet in Astro-Optoα1AR mice. We were able to identify arterioles that display diameter changes in superficial areas of the somatosensory cortex through the thinned skull. Photo-stimulation of astrocytes in the cortical area did not result in noticeable changes in the arteriole diameters compared with their background strain C57BL/6. Together, compelling evidence for astrocytic Gq pathway-induced vasodiameter changes was not observed. Our results support the notion that short-term (<10 s) hyperemia is not mediated by GPCR-induced astrocytic Ca2+ signaling.
8 July 2025 in Proceedings of the National Academy of Sciences
Local neural activation drives regional increase of cerebral blood flow (CBF), in a phenomenon known as functional hyperemia. Astrocytes, which enwrap cerebral blood vessels and respond to neuronal activity through their G protein–coupled receptors (GPCRs), play a vital role in brain energy metabolism. Although astrocytic calcium (Ca 2+ ) signaling has been widely studied in relation to neurovascular coupling, the role of cyclic adenosine monophosphate (cAMP), another key second messenger of GPCRs, on CBF has not been established. In this study, we explored the effects of optogenetically induced astrocytic cAMP elevation on CBF. We engineered adeno-associated viral vectors (AAVs) to express a bacterial photoactivated adenylyl cyclase in astrocytes, which triggers an increase in cAMP upon blue light stimulation. Opto-stimulation also elevated astrocytic Ca 2+ , albeit with a delayed onset under mild stimulation. In vivo imaging of anesthetized and awake wild-type mice through a thinned skull preparation revealed that optogenetically induced astrocytic cAMP elevation led to pronounced arteriole dilation, with a latency of 1.8 s and maximal dilation reached within 10 s in the awake state and slower response under anesthesia. Mild opto-stimulation causing sensory-level cAMP elevations was sufficient to induce arteriole dilation. This effect was preserved in IP 3 receptor type 2-knockout (IP 3 R2 −/− ) mice, indicating a mechanism independent of GPCR-induced intracellular Ca 2+ elevations. These findings highlight astrocytic cAMP as a key modulator of cerebral vasodilation, contributing to our understanding of local CBF regulation. This study opens broad avenues for understanding astrocyte-mediated control of CBF and its implications in neurological diseases characterized by dysregulated blood flow.
Sustained labeling of fluids is crucial for their investigation in animal models. Here, we introduce a mouse line (Alb-mSc-ST), where blood and interstitial fluid are labeled with the red fluorescent protein mScarlet and SpyTag. The SpyTag-SpyCatcher technology is exploited to monitor circulating fluid properties by biosensors or detect blood-brain barrier disruption. This approach represents a valuable tool for studying vascular structure, permeability and microenvironment in body organs in vivo .
SignificanceInvestigating blood microcirculation is important to better understand cardiovascular, metabolic, and neurodegenerative diseases. Although visualization of microcirculation has traditionally relied on the injection of short-lived fluorescent tracers, this approach poses challenges for experiments in awake animals or long-term imaging. To address these limitations, we previously developed a genetically encoded fluorescent plasma label that enables stable, minimally invasive in vivo visualization of vascular dynamics. Further optimizing its versatility and delivery will expand its utility in neuroscience and across diverse areas of biomedical research.AimWe aim to extend the utility of genetically encoded plasma labeling by testing brighter, more photostable fluorescent proteins and evaluating strategies to enhance adeno-associated viral (AAV)-mediated expression.ApproachAAV8 vectors encoding albumin fused to mNeonGreen or StayGold variants were administered systemically. Expression levels were tracked via blood sampling, and the effects of secondary AAV injection and immunomodulation were tested.ResultsAlb-mStayGold showed improved photostability but lower brightness than Alb-mNeonGreen. Secondary intraperitoneal AAV delivery successfully induced transgene expression even after prior AAV exposure. Moreover, higher AAV8-induced plasma label expression in males is confirmed. Immunosuppressant treatment increased plasma fluorescence, whereas neonatal AAV injection failed to induce tolerance.ConclusionPhotostable plasma labeling and immune modulation strategies expand the applicability of AAV-based vascular imaging.